ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.
SEC Commissioner Declares ‘No Reason For Us To Stand In The Way’ Of Bitcoin ETF: Is Gary Gensler Listening?
In the wake of crypto exchange Binance (CRYPTO: BNB) agreeing to a $4 billion settlement with the Justice Department, SEC Commissioner H
